[ad_1] BERLIN (Reuters) – The head of Germany’s vaccines regulator said some groups of people living in Germany could be vaccinated early next year against the coronavirus that has killed…
Tag: Pharmaceuticals & Medical Research (TRBC level 2)
S.Korea shares close at record high on chip, auto boost
[ad_1] * KOSPI hits record closing high, foreigners net buyers * KRW ends at strongest close since June 2018 vs USD * South Korea benchmark bond yield rises * For…
Link between COVID-19 shot, Swiss death ‘highly unlikely’ – drugs regulator
[ad_1] ZURICH (Reuters) – Swiss drugs regulator swissmedic on Wednesday said it saw no link between the death of a 91-year old person in the canton of Lucerne and the…
Roche says faricimab meets goals in trial against rivals’ Eylea
[ad_1] FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Swiss drugmaker Roche said on…
Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
[ad_1] LONDON (Reuters) – Treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive…
Germany sticks to recommendation on vaccine switch after first Astra dose
[ad_1] FILE PHOTO: A vial with AstraZeneca’s COVID-19 vaccine is prepared during a vaccination of teachers and nursery teachers, amid the spread of the coronavirus disease (COVID-19), in Grevesmuehlen, Germany,…
Take AstraZeneca’s ‘fantastic’ vaccine, Germany tells sceptical public
[ad_1] BERLIN (Reuters) – Germany’s government and health chiefs on Friday urged the public to take AstraZeneca’s coronavirus vaccine, seeking to stem a tide of scepticism about its effectiveness and…
Don’t use Gilead’s remdesivir in hospitalised COVID-19 patients, WHO says
[ad_1] LONDON (Reuters) – Gilead’s remdesivir should not be used for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival…
Allergan says offers undervalue business units for sale, shares fall
[ad_1] (Reuters) – Allergan Plc AGN.N on Tuesday expressed disappointment in early offers from potential buyers for business units it has been trying to sell, and its shares fell more…
Acadia to sell celebrity rehab center operator Priory for $1.47 billion
[ad_1] (Reuters) – Acadia Healthcare Co Inc said on Wednesday it would sell its UK unit the Priory Group, a care homes operator known for its celebrity clientele, to private…